Key words ankylosing spondylitis - non-radiographic axial spondyloarthritis - neck muscle -
            ultrasound - axial spondyloarthritis
Schlüsselwörter Axiale Spondyloarthritis - Spondylitis ankylosans - nicht röntgenologische axiale
            Spondyloarthritis - Ultraschall - Nackenmuskulatur
Introduction 
            Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that mainly affects
               the spine and sacroiliac joints. AxSpA is classified as ankylosing spondylitis
               (established AS) with sacroiliac joint involvement fulfilling the modified New York
               criteria (mNY criteria) and non-radiographic axial spondyloarthritis (nr-axSpA)
               without the sacroiliac joint involvement fulfilling mNY criteria detected by
               conventional radiography [1 ]. In both AS and
               nr-axSpA patients, symptoms such as the neck, low back, and gluteal pain, morning
               stiffness, difficulty in movement, fatigue, and sleep disturbance are observed, and
               these symptoms cause a decrease in quality of life [2 ].
            In axSpa, vertebral bodies, intervertebral discs, and paravertebral muscles of the
               spine undergo structural changes due to chronic inflammation. During the disease,
               sclerosis in the apophyseal joints, erosion and reactive sclerosis in the vertebral
               body, calcification in the interspinal ligaments, and intervertebral disc
               pathologies are observed. Atrophic changes occur in the paravertebral muscles due
               to
               chronic changes in the spine and limitation of movement, leading to impairment and
               disability in patients’ activities of daily living [2 ]
               [3 ]. In
               a study by Zhang et al., it was shown that the ratio of muscle fiber area to
               collagen fibril area in paraspinal muscle tissues decreased significantly in the
               histopathological examination of paraspinal muscles in patients with AS [4 ].
            It is hypothesized that patients with AxSpA may also experience changes in the
               cervical paravertebral muscle structure due to pain, spinal inflammation, limitation
               of movement, and increased neck flexion. To our knowledge, there is no study in the
               literature evaluating cervical paraspinal muscle (multifidus, semispinalis cervicis,
               semispinalis capitis, splenius capitis, and trapezius) thickness in patients with
               axSpA.
            This study examines the neck extensor muscle thicknesses of patients with AS and
               nr-axSpA by comparing them with healthy volunteers. It also aims to evaluate the
               relationship between muscle thickness and disease activity, functional parameters,
               neck disability, and quality of life.
         Methods 
            Study Design and Participation 
            
            A cross-sectional design was made to compare the ultrasound measurements of neck
               extensor muscle thickness of patients with AS, with nr-axSpA, with healthy
               participants. Patients meeting ASAS criteria for AxSpA were enrolled to the
               study [5 ]. Among these patients, patients
               who met the modified New York criteria were classified as AS and the other
               patients as nr-axSpA [6 ]. Thirty patients
               with AS and 30 patients with nr-AxSpA who were admitted to Kastamonu
               Rehabilitation Center Hospital Physical Medicine and Rehabilitation outpatient
               clinic , were included to the study consecutively [7 ]. Thirty healthy participants matched for
               age, sex, and Body Mass Index (BMI) were included as control group of the study.
               Patients who had trauma or spine surgery, inflammatory diseases other than AS
               and nr-axSpA, cervical spondylosis, cervical disc herniation, and a history of
               malignancy were excluded. The healthy group consisted of individuals who did not
               have chronic neck pain and were not diagnosed with any additional disease that
               could cause neck pain. The study was approved by the Ethics Committee of
               Kastamonu Training and Research Hospital
               (2020-KAEK-143–53/25.02.2021). The study was conducted in
               accordance with the Helsinki Declaration. Written informed consent was obtained
               from all participants.
            
            Clinical Assessment 
            
            Demographic and clinical data such as age, gender, and BMI of all participants in
               the study were recorded. Symptom duration, sacroiliac X-ray, and laboratory
               findings of patients with axSpA were also examined.
            
            In all patients with axSpA, the Bath Ankylosing Spondylitis Disease Activity
               Index (BASDAI) [8 ] for disease activity,
               the Bath Ankylosing Spondylitis Functional Index (BASFI) [9 ] for functional status, the Bath
               Ankylosing Spondylitis Metrology Index (BASMI) for spinal mobility [10 ] Ankylosing spondylitis Quality of Life
               (AsQoL) scale [11 ] for quality of life and
               Neck Disability Index (NDI) for neck disability [12 ] were applied.
            
            Ultrasound Measurement 
            
            Sonographic evaluations of the neck extensor muscles of the participants were
               performed with a 12 MHz linear probe (GE Logic BT12, GE Healthcare) by
               the same physician with ten years of US experience and who did not know in which
               group the participants were. The fourth cervical (C4) vertebral process was
               chosen as the US imaging level, similar to the protocol applied in a study
               evaluating the muscle thickness of the neck extensor muscles [13 ]. This level also was used in a study by
               Valera-Calero et al., that evaluated the cervical multifidus muscle morphology
               from the C4 level in healthy individuals [14 ]. The spinous process at the C4 level was determined by US-guided
               palpation and marked with an indelible marker pen in the prone position. After
               identification, each participant was seated upright in a chair with arms on
               their legs, and their head and neck were placed in a neutral position. The probe
               was placed transversely over the C4 spinous process and slid laterally until the
               echogenic vertebral lamina was clearly defined. The thickness of the multifidus,
               semispinalis capitis, semispinalis cervicis, splenius capitis, and trapezius
               muscles were measured bilaterally by determining the maximum distance between
               the fascial borders of each muscle when the muscles were at rest, and the
               average of the muscle thicknesses was recorded ([Fig. 1 ]).
            
            
                  Fig. 1  Ultrasound image for cervical extensor muscle thickness
                  measurements. 
            To test the intra-rater reliability, the same physician performed initial
               sonographic muscle thickness measurements in 30 healthy individuals according to
               the study methodology and repeated them ten days later.
            
            Statistical Analysis 
            
            The study population was determined as 81 using the G-power program by taking
               impact size 0.355 (based on similar study results) alpha=0.05, power
               (1-beta)=0.80 at a confidence level of 95%. A total of 90
               patients were included in the study, considering a dropout rate of
               25%.
            
            Statistical analysis was performed using the 23.0 SPSS (IBM, Armonk, NY, USA)
               statistical package program. In descriptive statistics, the number (%)
               was given for discrete variables, and mean±standard deviation or median
               (per 25–75) for continuous variables. Compliance of the data with normal
               distribution was evaluated with the Kolmogorov-Smirnov test and histogram. The
               Chi-square test was used for discrete variables to compare the differences
               between groups. Student t-test was used for pairwise comparison between groups
               with normal distribution, and Mann-Whitney U test was used for pairwise
               comparison between groups of data not conforming to normal distribution. One-way
               ANOVA was used to compare the three groups with normal distribution, and the
               Tukey test was used as a posthoc test to compare statistically significant
               parameters. Spearman correlation analysis was performed for abnormally
               distributed data. Whether the correlation coefficient calculated by the
               correlation analysis was statistically significant was tested with the
               “determination coefficient” (0.01 and 0.05). The significance
               level was accepted as p<0.05. The kappa score determined Intra-rater
               reliability.
            Results 
            The groups’ mean ages were 42.36±10.0 in AS group, 38.13±7.94
               in the nr-axSpA group, and 39.06±8.25 in the healthy group. While there were
               11 women and 19 men in the AS group, there were 14 women and 16 men in the nr-axSpA
               group and healthy group. There was no statistical difference between the three
               groups regarding age, gender, and BMI (respectively; p=0.152,
               p=0.665, p=0.673); and similar disease activity (BASDAI
               scores>4) were found between patients with AS and nr-axSpA
               (p=0.152). A statistically significant difference was found between the AS
               and nr-axSpA groups in terms of duration of symptoms, BASFI, BASMI, ASQoL, NDI, CRP,
               right and left sacroiliac grades (p=0.006, p=0.012, p=0.045,
               p=0.038, p=0.005, p=0.023, p<0.001,
               p<0.001). The demographic and clinical characteristics of the participants
               are given in [Table 1 ].
            
               
                  
                     
                     
                        Table 1  Demographic and clinical characteristics of the
                        participants.
                      
                  
                     
                     
                        
                        
                           AS Group (n=30)
                         
                        
                        
                           nr-axSpA Grubu (n=30)
                         
                        
                        
                           Healthy Group (n=30)
                         
                        
                        
                           p-value
                         
                         
                      
                  
                     
                     
                        
                        
                           Age (years)
                         
                        
                        
                           42.36±10.0
                         
                        
                        
                           38.13±7.94
                         
                        
                        
                           39.06±8.25
                         
                        
                        
                           0.152
                         
                         
                     
                     
                        
                        
                           Gender (F/M), n (%)
                         
                        
                        
                           11/19 (36.7/63.3)
                         
                        
                        
                           14/16 (46.7/53.3)
                         
                        
                        
                           14/16 (46.7/53.3)
                         
                        
                        
                           0.665
                         
                         
                     
                     
                        
                        
                           BMI (kg/m2)
                         
                        
                        
                           27.93±4.87
                         
                        
                        
                           27.47±4.08
                         
                        
                        
                           26.86±5.01
                         
                        
                        
                           0.673
                         
                         
                     
                     
                        
                        
                           Duration of symptoms (month)
                         
                        
                        
                           96 (48–180)
                         
                        
                        
                           60 (22.5–99)
                         
                        
                        
                           
                              0.006 
                              
                         
                         
                     
                     
                        
                        
                           BASDAI (>4), n (%)
                         
                        
                        
                           24 (80)
                         
                        
                        
                           19 (63.3)
                         
                        
                        
                           0.152
                         
                         
                     
                     
                        
                        
                           BASFI
                         
                        
                        
                           4.35 (1.90–6.73)
                         
                        
                        
                           1.95 (0.48–3.68)
                         
                        
                        
                           
                              0.012 
                              
                         
                         
                     
                     
                        
                        
                           BASMI
                         
                        
                        
                           0.5 (0–2.25)
                         
                        
                        
                           0 (0–1.0)
                         
                        
                        
                           
                              0.045 
                              
                         
                         
                     
                     
                        
                        
                           ASQoL
                         
                        
                        
                           12.0 (9.75–14)
                         
                        
                        
                           9.0 (5.0–12.0)
                         
                        
                        
                           
                              0.038 
                              
                         
                         
                     
                     
                        
                        
                           Neck Disability Index
                         
                        
                        
                           17.5 (11.0–26.25)
                         
                        
                        
                           11.0 (3.0–18.25)
                         
                        
                        
                           
                              0.005 
                              
                         
                         
                     
                     
                        
                        
                           CRP
                         
                        
                        
                           12.0 (2.5–19.5)
                         
                        
                        
                           4.0 (1.87–7.47)
                         
                        
                        
                           
                              0.023 
                              
                         
                         
                     
                     
                        
                        
                           Right sacroiliac grade
                         
                        
                        
                           3.5 (3.0–4.0)
                         
                        
                        
                           1.0 (1.0–2.0)
                         
                        
                        
                           
                              <0.001 
                              
                         
                         
                     
                     
                        
                        
                           Left sacroiliac grade
                         
                        
                        
                           3.0 (3.0–4.0)
                         
                        
                        
                           1.0 (0.75–1.0)
                         
                        
                        
                           
                              <0.001 
                              
                         
                         
                      
               
               
               AS: Ankylosing spondylitis; nr-axSpA: non-radiographic axial
                  spondyloarthritis; F: female; M: male; BMI: Body Mass Index;
                  (mean±standard deviation; n (%); median (per 25–75)
                  p<0.05 considered statistically significant).
                
            
            
            When the patients’ multifidus, semispinalis capitis, semispinalis cervicis,
               and splenius capitis muscle thicknesses were compared between the AS, nr-axSpA and
               healthy groups, there was a statistically significant difference (p<0.001
               p=0.008, p<0.001, p=0.020, respectively). When the
               statistically significant results were compared posthoc, there was a statistically
               significant difference between the AS and nr-axSpA groups in the multifidus,
               semispinalis capitis muscles (respectively, p=0.012, p=0.016).
               However, no statistical difference was found between the semispinalis cervicis and
               splenius capitis (respectively, p=0.965, p=0.325). Significant
               differences were found in the multifidus, semispinalis capitis, semispinalis
               cervicis, and splenius capitis muscles when the AS and healthy controls were
               compared ( respectively, p<0.001, p=0.021, p<0.001,
               p=0.015) . In the nr-axSpA and healthy groups comparison, there was a
               statistical difference in the semispinalis cervicis muscle, but no statistical
               difference was found in the multifidus, semispinalis capitis, and splenius capitis
               muscles (respectively, p=0.001, p=0.222, p=0.992,
               p=0.339). No statistical difference was found when the trapezius muscle
               thickness was compared between the groups (p=0.070) ([Table 2 ]).
            
               
                  
                     
                     
                        Table 2  Comparison of neck extensor muscle thickness between
                        groups.
                      
                  
                     
                     
                        
                        
                           AS Group (n=30)
                         
                        
                        
                           nr-axSpA Group (n=30)
                         
                        
                        
                           Healthy Group (n=30)
                         
                        
                        
                           p-value 
                         
                         
                      
                  
                     
                     
                        
                        
                           Multifidus (cm)
                         
                        
                        
                           1.31±0.15bc 
                              
                         
                        
                        
                           1.42±0.16a 
                              
                         
                        
                        
                           1.49±0.14a 
                              
                         
                        
                        
                           
                              <0.001 
                              
                         
                         
                     
                     
                        
                        
                           Semispinalis Capitis (cm)
                         
                        
                        
                           0.54±0.09bc 
                              
                         
                        
                        
                           0.62±0.11a 
                              
                         
                        
                        
                           0.61±0.12a 
                              
                         
                        
                        
                           
                              0.008 
                              
                         
                         
                     
                     
                        
                        
                           Semispinalis Cervicis (cm)
                         
                        
                        
                           0.46±0.10c 
                              
                         
                        
                        
                           0.47±0.09c 
                              
                         
                        
                        
                           0.57±0.11ab 
                              
                         
                        
                        
                           
                              <0.001 
                              
                         
                         
                     
                     
                        
                        
                           Splenius Capitis (cm)
                         
                        
                        
                           0.35±0.07c 
                              
                         
                        
                        
                           0.38±0.10
                         
                        
                        
                           0.41±0.09a 
                              
                         
                        
                        
                           
                              0.020 
                              
                         
                         
                     
                     
                        
                        
                           Trapezius (cm)
                         
                        
                        
                           0.15±0.03
                         
                        
                        
                           0.16±0.04
                         
                        
                        
                           0.17±0.03
                         
                        
                        
                           0.070
                         
                         
                      
               
               
               AS: Ankylosing spondylitis; nr-axSpA: non-radiographic axial
                  spondyloarthritis. a: Indicates the group that differs from the AS group. b:
                  b: indicates the group that differs from the nr-axSpA group. c: Indicates
                  the group that differs from the healthy group.
                
            
            
            Kappa scores were determined as 0.861 for multifidus, 0.790 for semispinalis capitis,
               0.722 for semispinalis cervicis, 0.679 for splenius capitis, and 0.741 for trapezius
               muscle to assess intra-rater reliability.
            The results of the correlation analysis between neck extensor muscle thickness
               (multifidus, semispinalis capitis, semispinalis cervicis, splenius capitis, and
               trapezius) and age, BMI, symptom duration, BASDAI, BASFI, BASMI, AsQoL, NDI, CRP,
               right and left sacroiliac grade of 60 patients diagnosed with axial SpA (AS,
               nr-axSpA) are shown in [Table 3 ].
            
               
                  
                     
                     
                        Table 3  Correlation analysis between neck extensor muscle
                        thicknesses and parameters in patients with axial SpA.
                      
                  
                     
                     
                        
                        
                           Multifidus
                         
                        
                        
                           Sscapitis
                         
                        
                        
                           SSservicis
                         
                        
                        
                           SPC
                         
                        
                        
                           Trapez
                         
                         
                      
                  
                     
                     
                        
                        
                           Age
                         
                        
                        
                           -,464**
                         
                        
                        
                           -,520**
                         
                        
                        
                           -,261*
                         
                        
                        
                           -,268*
                         
                        
                        
                           -0.060
                         
                         
                     
                     
                        
                        
                           BMI 
                         
                        
                        
                           -.243
                         
                        
                        
                           .003
                         
                        
                        
                           .197
                         
                        
                        
                           .040
                         
                        
                        
                           -.016
                         
                         
                     
                     
                        
                        
                           Duration of symptoms 
                         
                        
                        
                           -.123
                         
                        
                        
                           -.151
                         
                        
                        
                           .042
                         
                        
                        
                           .030
                         
                        
                        
                           -.068
                         
                         
                     
                     
                        
                        
                           BASDAI 
                         
                        
                        
                           -,428**
                         
                        
                        
                           -0.223
                         
                        
                        
                           -,346**
                         
                        
                        
                           -,353**
                         
                        
                        
                           -0.162
                         
                         
                     
                     
                        
                        
                           BASFI
                         
                        
                        
                           -.243
                         
                        
                        
                           -.075
                         
                        
                        
                           -.150
                         
                        
                        
                           -.195
                         
                        
                        
                           -,262*
                         
                         
                     
                     
                        
                        
                           BASMI
                         
                        
                        
                           -.067
                         
                        
                        
                           -.039
                         
                        
                        
                           .129
                         
                        
                        
                           -.165
                         
                        
                        
                           .091
                         
                         
                     
                     
                        
                        
                           AsQol
                         
                        
                        
                           -,335**
                         
                        
                        
                           -0.071
                         
                        
                        
                           -0.196
                         
                        
                        
                           -,392**
                         
                        
                        
                           -0.113
                         
                         
                     
                     
                        
                        
                           Neck Disability Index
                         
                        
                        
                           -,324*
                         
                        
                        
                           -,260*
                         
                        
                        
                           -0.239
                         
                        
                        
                           -,285*
                         
                        
                        
                           -0.253
                         
                         
                     
                     
                        
                        
                           CRP
                         
                        
                        
                           -.094
                         
                        
                        
                           .051
                         
                        
                        
                           .019
                         
                        
                        
                           -.198
                         
                        
                        
                           -.011
                         
                         
                     
                     
                        
                        
                           Right sacroiliac grade
                         
                        
                        
                           -.210
                         
                        
                        
                           -,306*
                         
                        
                        
                           .044
                         
                        
                        
                           -.071
                         
                        
                        
                           -.082
                         
                         
                     
                     
                        
                        
                           Left sacroiliac grade
                         
                        
                        
                           -.168
                         
                        
                        
                           -.157
                         
                        
                        
                           .093
                         
                        
                        
                           -.100
                         
                        
                        
                           -.037
                         
                         
                      
               
               
               *: p<0.05; **: p<0.001. BMI: Body
                  Mass Index. Spearman correlation analysis was performed and denoted as
                  rho.
                
            
            Discussion 
            To our knowledge and based on our detailed research in the literature, this is the
               first study to evaluate neck extensor muscle thickness by ultrasonography in
               patients with axSpA. As a result of the study, multifidus, semispinalis capitis,
               semispinalis cervicis, and splenius capitis muscle thicknesses were decreased in AS
               patients, and semispinalis cervicis muscle thicknesses were decreased in nr-axSpA
               patients compared to the healthy group. In addition, there was a significant
               negative correlation between neck extensor muscle thickness and age, disease
               activity index, neck disability index, and quality of life in patients with
               axSpA.
            Cervical extensor paraspinal muscles play an important role in stabilizing and moving
               the cervical spine in the neck. They help the lateral flexion of the spine to the
               same side when contracted unilaterally and the extension movement of the spine when
               contracted bilaterally. Structural and morphological changes in the muscles cause
               early symptoms such as pain, stiffness, and posture disorder. In cases such as
               persistent pain and inflammation and phobia of exercises due to pain, limitation of
               movement and muscle atrophy can occur, which causes the pain to become chronic and
               limiting the person’s daily living activities. In a study conducted on
               office workers with unilateral chronic neck pain, it was found that semispinalis
               capitis muscle thickness was decreased compared to the control group evaluated by
               ultrasonography [15 ]. In a study by Penas et
               al., it was found that the cross-sectional area of the multifidus muscle was lower
               in women with chronic neck pain compared to the control group [16 ]. Goodarzi et al. found a significant
               difference in the participants’ resting multifidus, semispinalis cervicis,
               semispinalis capitis, splenius capitis, and trapezius muscle thicknesses with
               forward head posture compared to those with normal head posture [13 ]. These studies in the literature show the
               relationship between muscle thickness and pain/posture disorder. Similarly,
               in the present study, when compared to the control group, the thickness of the
               muscles other than the trapezius was significantly lower in the AS group. In the
               nr-axSpa group, only the semispinalis cervicis muscle thickness was significantly
               reduced compared to the control group. The major decrease in muscle thickness in the
               AS group is thought to be since chronic inflammation, immobilization, and postural
               changes are more established over time.
            There is no study in the literature evaluating paraspinal muscles in the neck in
               AxSpA patients. The number of studies evaluating the lumbar paraspinal muscles is
               few [17 ]
               [18 ]. Akgul et al. evaluated the cross-sectional area and fat infiltration
               of the paraspinal muscles (multifidus, erector spinae, psoas) in patients with
               nr-axSpA and established AS with MRI. They found that the paraspinal
               muscles’ cross-sectional area was similar between the groups, and patients
               with AS had higher degrees of fat infiltration than patients with nr-axSpA [17 ]. Resorlu et al. compared multifidus and
               erector spinae muscle cross-sectional areas and fatty degenerations in the lumbar
               region between AS patients and the control group. Paravertebral muscle
               cross-sectional areas and fatty degeneration were higher in AS patients compared to
               the control group.
            Additionally, a negative correlation was observed between the cross-sectional area
               of
               paravertebral muscles and the duration of the disease [18 ]. Although the anatomy of the cervical and
               lumbar spine regions and their involvement in the axSpA are different, in the
               present study in which the cervical paraspinal muscles were evaluated, findings
               consistent with the studies performed in the lumbar region were found. A
               statistically significant difference was found in paravertebral muscle thickness
               between AS, nr-axSpA, and control groups. Moreover, there was a significant negative
               correlation between disease duration and muscle thickness.
            Magnetic resonance imaging, computed tomography, and ultrasonography are frequently
               used in evaluating the cervical spine and paraspinal muscles. Ultrasound is
               frequently preferred recently in evaluating the musculoskeletal system because it
               does not contain radiation, is inexpensive, and is easily accessible. However, it
               is
               known that it depends on the person’s experience doing it [19 ]. A systemic review emphasized that
               ultrasonography is a reliable and valid method for cervical muscle evaluation [20 ]. In a study by Nagai et al. in which the
               gender differences in neck flexor and extensor muscle thicknesses were compared with
               ultrasound, they did not find a statistical difference between men and women in
               cervical extensor muscle thicknesses. In addition, intra-class correlation
               coefficient (ICC) intra-rater reliability was 0.852 [21 ]. In this study, the ICC was found to be between 0.679 and 0.861. The
               findings show that ultrasound is an effective diagnostic method for evaluating neck
               paravertebral muscle thickness in axSpa patients.
            In diseases with chronic neck pain, muscle strength and volume decrease over time
               due
               to various reasons, and this situation becomes a vicious circle with more pain and
               stiffness. Therefore, neck exercises are important in preserving the existing muscle
               volume and stabilizing the spine in diseases that tend to become chronic. Kashfi et
               al. compared the effectiveness of general exercise and deep neck muscle-specific
               neck exercises in patients with chronic neck pain. While both exercise treatments
               are effective, the importance of a specific exercise program for deep neck muscles
               has been emphasized both on pain and to reduce chronic complications [22 ]. Exercise plays a vital role in the
               rehabilitation process of axSpA patients. Regular exercise is vital in this patient
               group to increase mobility, endurance, and strength, reduce pain and increase the
               quality of life of the patients [23 ]. A study
               by Öztürk et al. concluded that atrophy occurs in the paravertebral
               muscles due to increased thoracic kyphosis, mechanical stress and inflammatory pain,
               and immobilization in patients with AS and nr-axSpA [24 ]. The present study determined that neck muscle thicknesses decreased
               in patients with AS, nr-axSpA compared to the control group. The importance of
               exercise therapy is emphasized in patients with established AS and in patients who
               have not yet completed their evolution and whose disease duration is short.
            Therefore, planning a specific exercise program for the paravertebral muscles in the
               early period in patients with axSpA will positively affect possible pain,
               disability, and quality of life.
            The correlation analysis determined a negative correlation between muscle thickness
               and age, BASDAI, AsQol, NDI scores. In addition, a negative correlation was found
               between trapezius muscle thickness and BASFI and sacroiliac joint grade and SSC.
               This explains that as mobility impairment and radiologic progression increase ,
               paraspinal muscle involvement is more significant. Since AS and nr-axSpA are chronic
               inflammatory processes, we think the relationship between paraspinal muscle
               thickness and functional index, quality of life scale, and neck disability index is
               bidirectional rather than a cause-effect relationship. For this reason, atrophy in
               cervical neck extensors causes increased neck pain, worsening in functional status,
               deterioration in the quality of life, and as a result, the chain of the vicious
               circle cannot be broken, resulting in a decrease in the thickness of the muscles due
               to pain and immobility.
            The limitations of the study include evaluating cervical muscle thickness only at
               the
               C4 level, not using muscle cross-sectional area, and measuring only resting muscle
               thickness. The number of our patients was small, which may have caused inadequacy
               in
               the statistical evaluation of the data. In addition, our study was a cross-sectional
               study, so the effects of the patients in the future follow-up are not known.
               However, the strength of this study is that it is the first study in which muscle
               thickness was compared with ultrasound in both AS and nr-axSpA patients.
         Conclusion 
            In conclusion, neck extensor muscle thicknesses are decreased in patients with AxSpA
               compared to healthy individuals, and this situation can be reliably detected by
               ultrasound. This study will guide studies that will examine the neck muscles in
               detail with large patient groups diagnosed with AxSpA.